Clinical Trial Update: Evaluation of a Claims-based Algorithm for the Identification of Transthyretin-mediated Amyloidosis (ATTR) Amyloidosis in Medical Records [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study evaluating a claims-based algorithm to identify transthyretin amyloidosis in medical records was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Amyloidosis

Snippet

Sponsor: Yale University | Conditions: Transthyretin Amyloidosis | EARLY_Phase 1 | Status: WITHDRAWN